ETF Morning Review | Chemical pharmaceuticals strengthen, Hang Seng Innovation Drug ETF Huatai-PineBridge (520500) up 6.73%, GF Hong Kong Innovation Drug ETF (513120) leads in trading volume

SadMoneyMeow · 2026-04-01T19:47:02+00:00

As of midday close, the Shanghai Composite Index rose by 1.36%, and the Shenzhen Component Index increased by 1.20%. The chemical pharmaceuticals, biopharmaceuticals, and healthcare services sectors performed notably. In terms of ETFs, the Hang Seng Innovation Drug ETF saw the largest increase, while the S&P Oil & Gas ETF experienced a significant decline. Trading volume was concentrated in products like the Hong Kong Stock Exchange Innovation Drug ETF.

SadMoneyMeow

2026-04-01 19:47:02

Abstract generation in progress

Tongbi Finance April 1 news. As of the midday close, the Shanghai Composite Index rose 1.36%, the Shenzhen Component Index rose 1.20%, and the ChiNext Index rose 1.18%. Chemical and pharmaceutical, biological products, and medical services led the gains, while Sports II, Forestry II, and Rail Transit Equipment II collectively pulled back.

In terms of ETF daily price change percentages, as of midday, the top five by gain were: Hang Seng Innovative Drug ETF Huatai-Perry (520500) up 6.73%, Hong Kong Stock Connect Innovative Drug ETF Southern (159297) up 6.60%, STAR Market Innovative Drug ETF E Fund (589120) up 6.55%, STAR Market Innovative Drug ETF Gaiming (589720) up 6.51%, and Hong Kong Stock Connect Innovative Drug ETF Penghua (159286) up 6.47%.

The top five by decline were: S&P Oil & Gas ETF Woolsworth (513350) down 5.46%, S&P Oil & Gas ETF China Universal (159518) down 4.81%, Energy & Chemical ETF CCB (159981) down 1.16%, Satellite ETF Woolsworth (563230) down 1.00%, and New Energy ETF Shenwan Llink (159752) down 0.98%.

For ETF trading value, the top ten by half-day trading value were: Hong Kong Stock Innovative Drug ETF GF (513120) 6.161 billion yuan, CSI A500 ETF Gaiming (159338) 4.029 billion yuan, A500 ETF Huatai-Perry (563360) 3.986 billion yuan, A500 ETF Southern (159352) 3.915 billion yuan, Gold ETF Hu an (518880) 3.750 billion yuan, Hong Kong Securities ETF E Fund (513090) 3.720 billion yuan, A500 ETF Huaxia (512050) 3.545 billion yuan, Hang Seng Tech ETF Huatai-Perry (513130) 3.343 billion yuan, Hong Kong Stock Connect Innovative Drug ETF E Fund (159570) 2.887 billion yuan, and Hang Seng Tech ETF Huaxia (513180) 2.853 billion yuan. (Note: excluding money market ETFs and bond ETFs)

(责任编辑：董萍萍）

     【免责声明】This article only represents the author’s personal views and is not related to Hexun. The Hexun website maintains neutrality toward the statements and judgmental views made in the text, and does not provide any express or implied guarantees regarding the accuracy, reliability, or completeness of the content included. Readers are asked to use it for reference only and assume all responsibility themselves. Email: news_center@staff.hexun.com

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.